Documents

Study Qualitative evaluation of completed projects funded by the ERC 2019

Published on
| 6 years ago
Programmes
  • ERC
ERC monitors the impact of the research funded by organising a qualitative evaluation of the research outcome of finalised projects annually. This study evaluated a total of 225 ERC projects, funded under the European Union’s 7th Framework Programme (FP7), in 25 independent peer-review panels. The study found that 18% of projects analysed had resulted in a scientific breakthrough and 61.9% had made major scientific advances. 17.6% of projects had made an incremental scientific contribution, whilst 2.5% of the assessed projects provided no appreciable scientific contribution. Half of the projects already had an impact on the economy, society and policy-making, and around two thirds are expected to have such impact in the medium to long term.

myOverview

Sign up for personalised information

Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.

  • News in your domains
  • Event announcements
  • A personal dashboard
Sign up now

Only for stakeholders located in Flanders

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.